| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |